The resurgence of measles in Texas, United States, poses a significant public health threat that requires immediate intervention. Despite measles being declared eliminated in the U.S. in 2000, recent outbreaks in Texas highlight alarming vaccination gaps, misinformation, and inadequate healthcare access in vulnerable communities. This study explores the epidemiological trends, underlying causes, and socio-demographic factors contributing to the resurgence of measles in Texas between 2019 and 2024. A review of CDC and a few state and local health departments’ publicly accessible data and publications highlights key drivers of recent outbreaks, particularly vaccine hesitancy, misinformation, and policy gaps. Additionally, underserved populations lacking access to healthcare remain at high risk of infection. We recommend strengthened public health policies promoting vaccination, community-driven awareness campaigns, and enhanced surveillance systems to mitigate future outbreaks. Mobile clinics should also be deployed to deliver convenient and focused vaccination services thereby expanding vaccine accessibility and reaching underprivileged communities. Implementing digital surveillance systems that enables real-time tracking of vaccination rates, swift detection of outbreaks, and predictive modeling of transmission patterns to ultimately inform data-driven interventions to prevent the spread of measles. Additionally, immediate collaborative efforts between public health authorities, policymakers, and local communities are essential to prevent further spread and protect population health.
Type 1 diabetes mellitus (T1D) is a common autoimmune disease during childhood with a substantial genetic component. Individual genome-wide association studies (GWAS) often have limited power and are predominantly based on European-ancestry populations. To provide a more robust synthesis of genetic associations, we conducted a meta-analysis using summary-level GWAS data from three independent pediatric T1D studies obtained from the NHGRI-EBI GWAS Catalog. Harmonized single-nucleotide polymorphisms (SNPs) shared across all datasets were analyzed using inverse-variance weighted fixed-effects and random-effects models, with between-study heterogeneity assessed using Cochran’s Q test and the statistic. Of the 4,297,702 million common SNPs analyzed, 3524 reached genome-wide significance (), demonstrating strong and consistent associations with T1D risk. The most prominent signals clustered on chromosome 6, consistent with known immune-related loci, and included both risk-increasing and protective variants, in agreement with prior biological findings. Heterogeneity across studies was minimal, with values near for nearly all SNPs. These findings highlight robust and reproducible SNP-level associations with pediatric T1D, providing an updated foundation for functional follow-up and translational studies.
26 May 2026 in Bioinformatics and Biology Insights
Overuse of antimicrobial drugs is known to cause an increase in bacterial resistance among surviving pathogens, reducing the effectiveness of future treatments. Publicly available sequencing collections, such as the National Center for Biotechnology Information Sequence Read Archive (SRA), allow for global investigation of antimicrobial resistance across pathogens. In this study, we developed a pipeline to process 10 803 globally sourced unique bacterial isolates from publicly available SRA datasets (9 pathogens, 4 antibiotics), representing sequencing data generated by multiple laboratories using diverse sequencing platforms and protocols. The pipeline extracted SRA metadata to determine read layout and length, applied quality control, trimming, and decontamination. Preprocessed isolates were mapped reads to an antimicrobial resistance gene class and to a strain-level genome reference library constructed from complete genomes on the SRA submitted between 2009 and 2020. Three classifiers—L1-penalized logistic regression, random forest, and extreme gradient boosting—were trained on the resulting feature matrices, and their outputs were combined in a majority-vote ensemble. Internal training resulted in 83.8% balanced accuracy on average, and external testing yielded 80.2%. Variable importance analyses identified known resistance gene classes and strain markers such as Acinetobacter baumannii LAC-4 and Campylobacter jejuni 81-176 and NCTC13255, confirming biological relevance. This work demonstrates a scalable approach for antimicrobial resistance prediction using heterogeneous sequencing data.
Background: From 2018 to 2023, Human papillomavirus (HPV) vaccination coverage in the United States was shaped by both proactive immunization efforts and the disruptions caused by the COVID-19 pandemic, leading to the first national decline in nearly a decade. This study aimed to assess vaccination trends over time and across regions to identify coverage gaps and inform health policy best practices for achieving optimal HPV vaccination rates. Methods: We used provider-verified data from the National Immunization Survey–Teen for adolescents aged 13–17, focusing on vaccine initiation (≥1 dose) and up-to-date (UTD) status, as defined by Centers for Disease Control and Prevention guidelines. We used Cochran-Armitage trend tests to assess changes across the pre-pandemic, pandemic, and post-pandemic periods. We stratified our analyses by sex, race/ethnicity, and state. Results: Initiation increased from 68.1% in 2018 to 76.9% in 2021, then declined to 76.8% in 2023. UTD status rose from 51.1 to 62.6% by 2022 but fell to 61.4% in 2023. Females and Hispanic/Black adolescents consistently had higher coverage than males and White adolescents. Eighteen states, mainly in the Northeast and Upper Midwest, achieved ≥80% initiation by 2023, while Southern states lagged. Conclusion: Best practices for improving HPV vaccination include: (1) strengthening vaccination infrastructure in low-performing Southern states, (2) targeting male and White adolescents, (3) maintaining robust delivery systems during crises, and (4) replicating high-performing regional models. These strategies can improve vaccine equity and contribute to achieving national targets over time and space.